UPDATE: Rigel Pharma (RIGL) Reports Collaboration and License Agreement with Grifols S.A. (GRFS) to Commercialize Fostamatinib Disodium Hexahydrate in Europe and Turkey
Tweet Send to a Friend
(Updated - January 23, 2019 7:36 AM EST)
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) today announced that it has entered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) today announced that it has entered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
